Trustmark National Bank Trust Department’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Sell |
34,525
-1,472
| -4% | -$85.8K | 0.13% | 114 |
|
|
2025
Q4 | $1.94M | Sell |
35,997
-1,212
| -3% | -$58.3K | 0.12% | 117 |
|
|
2025
Q3 | $1.68M | Sell |
37,209
-9,216
| -20% | -$430K | 0.11% | 125 |
|
|
2025
Q2 | $2.15M | Sell |
46,425
-32,341
| -41% | -$1.59M | 0.15% | 105 |
|
|
2025
Q1 | $4.8M | Buy |
78,766
+22,451
| +40% | +$1.31M | 0.36% | 63 |
|
|
2024
Q4 | $3.19M | Buy |
56,315
+17,945
| +47% | +$1M | 0.24% | 84 |
|
|
2024
Q3 | $1.99M | Sell |
38,370
-19,221
| -33% | -$902K | 0.15% | 110 |
|
|
2024
Q2 | $2.39M | Sell |
57,591
-8,511
| -13% | -$381K | 0.19% | 95 |
|
|
2024
Q1 | $3.58M | Sell |
66,102
-23,937
| -27% | -$1.22M | 0.29% | 79 |
|
|
2023
Q4 | $4.62M | Buy |
90,039
+19,956
| +28% | +$1.05M | 0.42% | 60 |
|
|
2023
Q3 | $4.07M | Sell |
70,083
-3,862
| -5% | -$237K | 0.4% | 58 |
|
|
2023
Q2 | $4.73M | Sell |
73,945
-4,717
| -6% | -$316K | 0.44% | 57 |
|
|
2023
Q1 | $5.45M | Sell |
78,662
-26,251
| -25% | -$1.85M | 0.5% | 49 |
|
|
2022
Q4 | $7.55M | Buy |
104,913
+247
| +0.2% | +$18.6K | 0.7% | 34 |
|
|
2022
Q3 | $7.44M | Sell |
104,666
-3,364
| -3% | -$244K | 0.72% | 31 |
|
|
2022
Q2 | $8.32M | Buy |
108,030
+6,823
| +7% | +$520K | 0.75% | 32 |
|
|
2022
Q1 | $7.39M | Buy |
101,207
+1,509
| +2% | +$101K | 0.59% | 45 |
|
|
2021
Q4 | $6.22M | Buy |
99,698
+704
| +0.7% | +$41.3K | 0.47% | 56 |
|
|
2021
Q3 | $5.86M | Sell |
98,994
-7,100
| -7% | -$468K | 0.47% | 54 |
|
|
2021
Q2 | $7.09M | Buy |
106,094
+1,543
| +1% | +$101K | 0.56% | 43 |
|
|
2021
Q1 | $6.6M | Buy |
104,551
+13,352
| +15% | +$831K | 0.55% | 45 |
|
|
2020
Q4 | $5.66M | Buy |
91,199
+13,057
| +17% | +$803K | 0.51% | 47 |
|
|
2020
Q3 | $4.71M | Buy |
78,142
+834
| +1% | +$50.2K | 0.47% | 54 |
|
|
2020
Q2 | $4.55M | Buy |
77,308
+4,304
| +6% | +$257K | 0.47% | 51 |
|
|
2020
Q1 | $4.07M | Buy |
73,004
+2,862
| +4% | +$175K | 0.49% | 54 |
|
|
2019
Q4 | $4.5M | Buy |
70,142
+4,620
| +7% | +$265K | 0.42% | 54 |
|
|
2019
Q3 | $3.32M | Sell |
65,522
-1,351
| -2% | -$63.5K | 0.33% | 67 |
|
|
2019
Q2 | $3.03M | Sell |
66,873
-1,515
| -2% | -$70.6K | 0.3% | 71 |
|
|
2019
Q1 | $3.26M | Sell |
68,388
-2,786
| -4% | -$139K | 0.33% | 68 |
|
|
2018
Q4 | $3.7M | Buy |
71,174
+3,579
| +5% | +$192K | 0.42% | 56 |
|
|
2018
Q3 | $4.2M | Sell |
67,595
-776
| -1% | -$46.1K | 0.42% | 53 |
|
|
2018
Q2 | $3.78M | Buy |
68,371
+4,080
| +6% | +$220K | 0.44% | 54 |
|
|
2018
Q1 | $4.07M | Buy |
64,291
+4,707
| +8% | +$303K | 0.44% | 55 |
|
|
2017
Q4 | $3.65M | Buy |
59,584
+11,703
| +24% | +$732K | 0.4% | 64 |
|
|
2017
Q3 | $3.05M | Sell |
47,881
-440
| -0.9% | -$25.7K | 0.35% | 68 |
|
|
2017
Q2 | $2.69M | Sell |
48,321
-1,826
| -4% | -$99.4K | 0.31% | 75 |
|
|
2017
Q1 | $2.73M | Sell |
50,147
-2,807
| -5% | -$154K | 0.33% | 75 |
|
|
2016
Q4 | $3.09M | Sell |
52,954
-1,850
| -3% | -$101K | 0.41% | 57 |
|
|
2016
Q3 | $2.96M | Sell |
54,804
-70
| -0.1% | -$4.5K | 0.36% | 70 |
|
|
2016
Q2 | $4.04M | Sell |
54,874
-9,990
| -15% | -$706K | 0.52% | 48 |
|
|
2016
Q1 | $4.14M | Sell |
64,864
-2,020
| -3% | -$127K | 0.56% | 43 |
|
|
2015
Q4 | $4.6M | Sell |
66,884
-2,240
| -3% | -$148K | 0.63% | 39 |
|
|
2015
Q3 | $4.09M | Buy |
69,124
+750
| +1% | +$47.6K | 0.57% | 46 |
|
|
2015
Q2 | $4.55M | Buy |
68,374
+755
| +1% | +$49.8K | 0.61% | 40 |
|
|
2015
Q1 | $4.36M | Sell |
67,619
-5,830
| -8% | -$365K | 0.58% | 41 |
|
|
2014
Q4 | $4.33M | Sell |
73,449
-13,503
| -16% | -$762K | 0.59% | 42 |
|
|
2014
Q3 | $4.45M | Sell |
86,952
-41
| -0% | -$2.05K | 0.63% | 40 |
|
|
2014
Q2 | $4.22M | Sell |
86,993
-731
| -0.8% | -$36K | 0.48% | 43 |
|
|
2014
Q1 | $4.56M | Sell |
87,724
-12,522
| -12% | -$666K | 0.53% | 36 |
|
|
2013
Q4 | $5.33M | Buy |
100,246
+3,949
| +4% | +$201K | 0.63% | 30 |
|
|
2013
Q3 | $4.46M | Buy |
96,297
+2,075
| +2% | +$91.1K | 0.55% | 36 |
|
|
2013
Q2 | $4.21M | Buy |
+94,222
| New | +$4.09M | 0.55% | 36 |
|
Other funds holding BMY
VCM
VPM
Trustmark National Bank Trust Department's BMY Position: Q1 2026 in Review
Trustmark National Bank Trust Department reduced its Bristol-Myers Squibb (BMY) stake by 4.1% in Q1 2026, selling an estimated $85.8K and leaving 34,525 shares worth $2.09M. The position accounts for 0.13% of the portfolio, ranked #114.
Trustmark National Bank Trust Department first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.32M in Q2 2022. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Trustmark National Bank Trust Department held 34,525 shares of Bristol-Myers Squibb worth $2.09M as of Q1 2026.
- Trustmark National Bank Trust Department sold 1,472 Bristol-Myers Squibb shares in Q1 2026, an estimated $85.8K.
- Bristol-Myers Squibb made up 0.13% of Trustmark National Bank Trust Department's portfolio in Q1 2026, its #114 holding.
- Trustmark National Bank Trust Department first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Trustmark National Bank Trust Department's Bristol-Myers Squibb position peaked at $8.32M in Q2 2022.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.